FI870796A - Naftotiazepinoner och deras framstaellning. - Google Patents

Naftotiazepinoner och deras framstaellning. Download PDF

Info

Publication number
FI870796A
FI870796A FI870796A FI870796A FI870796A FI 870796 A FI870796 A FI 870796A FI 870796 A FI870796 A FI 870796A FI 870796 A FI870796 A FI 870796A FI 870796 A FI870796 A FI 870796A
Authority
FI
Finland
Prior art keywords
naftotiazepinoner
deras framstaellning
och deras
och
framstaellning
Prior art date
Application number
FI870796A
Other languages
English (en)
Finnish (fi)
Other versions
FI870796A0 (fi
Inventor
Erno Mohacsi
Jay Philip O'brien
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI870796A0 publication Critical patent/FI870796A0/fi
Publication of FI870796A publication Critical patent/FI870796A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FI870796A 1986-02-26 1987-02-24 Naftotiazepinoner och deras framstaellning. FI870796A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/834,178 US4652561A (en) 1986-02-26 1986-02-26 Naphtho[1,2-b]-1,4-thiazepinones

Publications (2)

Publication Number Publication Date
FI870796A0 FI870796A0 (fi) 1987-02-24
FI870796A true FI870796A (fi) 1987-08-27

Family

ID=25266290

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870796A FI870796A (fi) 1986-02-26 1987-02-24 Naftotiazepinoner och deras framstaellning.

Country Status (16)

Country Link
US (1) US4652561A (fr)
EP (1) EP0234561A3 (fr)
JP (1) JPS62205067A (fr)
KR (1) KR900003369B1 (fr)
AU (1) AU594124B2 (fr)
CA (1) CA1272717A (fr)
DK (1) DK93787A (fr)
FI (1) FI870796A (fr)
HU (1) HU197732B (fr)
IL (1) IL81676A (fr)
MC (1) MC1792A1 (fr)
NO (1) NO167285C (fr)
NZ (1) NZ219386A (fr)
PH (1) PH23214A (fr)
PT (1) PT84358B (fr)
ZA (1) ZA871144B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61939B1 (en) * 1987-07-31 1994-11-30 Tanabe Seiyaku Co Naphthothiazepine derivatives and a process for preparing the same
US4808580A (en) * 1987-12-17 1989-02-28 Hoffmann-La Roche Inc. Naphtho[1,2-b][1,4]thiazepin-4(5H)-ones and use thereof in treatment of ischemia and blood pressure lowering
US4912102A (en) * 1988-02-01 1990-03-27 Hoffmann-La Roche Inc. Analogs of naphtho[1,2-β] [1,4] thiazepin-4(5H)-one
US4996352A (en) * 1988-05-10 1991-02-26 Hoffmann-La Roche Inc. Enantiomers of β-[(2-amino-1-naphthalenyl) thiol]-α-hydroxy-4-methoxybenzene propanoic acid
US5225557A (en) * 1988-05-10 1993-07-06 Hoffmann-La Roche Inc. Process for making optically active naphtho[1,2-b]thiazepin-4(5H)-ones
US4864058A (en) * 1988-05-10 1989-09-05 Hoffmann-La Roche Inc. Process for making optically active naphtho[1,2-b][1,4]thiazepin-4(5H)-ones
US5008411A (en) * 1988-05-24 1991-04-16 Hoffmann-La Roche Inc. Glycidic acid ester and process of preparation
ZA893392B (en) * 1988-05-24 1990-01-31 Hoffmann La Roche Process for the manufacture of optically active naphthothiazepinones
JPH0637480B2 (ja) * 1988-10-29 1994-05-18 田辺製薬株式会社 ナフトチアゼピン誘導体
GB9315600D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Compounds
GB9315566D0 (en) * 1993-07-28 1993-09-08 Smithkline Beecham Plc Medicaments
KR100707050B1 (ko) * 2002-11-28 2007-04-13 에스케이 주식회사 10Ｈ-디벤조[ｂ,ｆ][1,4]티아제핀-11-온의 제조방법
US20050159403A1 (en) * 2003-04-22 2005-07-21 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damage
US20060135506A1 (en) * 2003-04-22 2006-06-22 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
DE102004013678A1 (de) * 2004-03-18 2005-10-20 Micronas Gmbh Vorrichtung zur Detektion eines Gases oder Gasgemischs
KR101233139B1 (ko) * 2011-04-21 2013-02-21 주식회사 한서켐 라세믹 1,4-티아제핀 화합물의 분할 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
BR6915295D0 (pt) * 1969-01-25 1973-04-12 Tanabe Seiyaku Co Indicador cronologico de evento em transmissao televisada
JPS5899471A (ja) * 1981-12-07 1983-06-13 Tanabe Seiyaku Co Ltd ベンゾチアゼピン誘導体の新規製造法
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
IT1206505B (it) * 1983-07-22 1989-04-27 Schiapparelli Farma Nuovi derivati benzotiazepinonici, metodo per la loro preparazione e composizioni farmaceutiche che licontengono.
US4490292A (en) * 1983-10-07 1984-12-25 Hamari Chemicals, Ltd. 1,5-Benzothiazepine derivatives and production thereof
US4590188A (en) * 1984-02-18 1986-05-20 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and their pharmaceutical use
IL71538A (en) * 1984-04-13 1987-07-31 Abic Ltd Process for the preparation of benzothiazepine derivatives
IE61939B1 (en) * 1987-07-31 1994-11-30 Tanabe Seiyaku Co Naphthothiazepine derivatives and a process for preparing the same

Also Published As

Publication number Publication date
IL81676A (en) 1991-03-10
NO870782D0 (no) 1987-02-25
NO167285B (no) 1991-07-15
US4652561A (en) 1987-03-24
FI870796A0 (fi) 1987-02-24
MC1792A1 (fr) 1987-10-22
PT84358A (en) 1987-03-01
HUT45241A (en) 1988-06-28
CA1272717A (fr) 1990-08-14
PH23214A (en) 1989-06-06
HU197732B (en) 1989-05-29
DK93787D0 (da) 1987-02-24
EP0234561A3 (fr) 1988-04-06
KR900003369B1 (ko) 1990-05-16
NO870782L (no) 1987-08-27
AU6925587A (en) 1987-08-27
NO167285C (no) 1991-10-23
KR870007905A (ko) 1987-09-22
IL81676A0 (en) 1987-09-16
DK93787A (da) 1987-08-27
EP0234561A2 (fr) 1987-09-02
NZ219386A (en) 1990-06-26
AU594124B2 (en) 1990-03-01
JPS62205067A (ja) 1987-09-09
PT84358B (pt) 1989-11-10
ZA871144B (en) 1987-10-28

Similar Documents

Publication Publication Date Title
FI870255A (fi) Olja och vatten avstoetande kopolymerer.
FI870275A (fi) Fotopolymeriserbar blandning och denna innehaollande fotopolymeriserbara maerkningsaemnen.
FI870233A (fi) Vakumisolerad skeppcontainer och foerfarande.
FI865351A (fi) Luftfoerdelningssystem och luftfoerdelningsanlaeggning.
FI870796A (fi) Naftotiazepinoner och deras framstaellning.
FI870246A0 (fi) Antiischemiska och antihypertensiva dihydropyridinfoereningar.
FI862675A0 (fi) Anordning foer provbelastning och kvalitetskontroll.
FI862161A0 (fi) Dragkrok och skyddsanordning foer dragkroket.
FI864911A (fi) Mikrobiologisk odlingskammare och laesapparat.
FI864114A0 (fi) Haolighetskonstruktion och foerfarande foer framstaellning daerav.
FI860706A0 (fi) Sammanfogningsmetod foer fyrkantskanaler och luftkonditioneringsmaskiner.
FI860691A0 (fi) Byggnadssystem och vaeggelement.
FI865372A0 (fi) Hinderdetektor foer fordon och liknande.
FI860535A0 (fi) Roerbyggd staellning foer haengmatta reservbaedd och torkning.
FI863380A0 (fi) Foerfarande och anordning foer temperaturreglering.
FI864494A0 (fi) Varnings- och varselpelare foer trafik och deras uppresningsanordningssystem.
FI864492A0 (fi) En straolningsreflekterande och vaermeisolerande paose.
FI864288A0 (fi) Maerkespaole och- roese foer graens och maetpunkt.
FI864248A0 (fi) Kinazolinderivat och foerfarande foer deras framstaellning.
FI864174A0 (fi) Framstaellningsfoerfarande foer kombinerat fosforgoedslingsmedel och jordfoerbaettringsmedel.
FI864132A0 (fi) Haolighetskonstruktion och foerfarande foer framstaellning daerav.
FI864115A0 (fi) Foerfarande och anlaeggning foer vaermekraftsprocess.
FI860970A0 (fi) Foerfarande foer traodbaogsvetsning och skaerbraenning.
FI863939A0 (fi) Matarroer foer stycketorvs-/ granuleringsmaskin och foerfarande foer framstaellning daerav.
FI863888A0 (fi) Skivformig sandwichprodukt foer paermar och liknande.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: F. HOFFMANN-LA ROCHE AG